9VG0 image
Deposition Date 2025-06-12
Release Date 2025-09-24
Last Version Date 2025-10-01
Entry Detail
PDB ID:
9VG0
Keywords:
Title:
SIRT2 structure in complex with H3K18myr peptide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
1.61 Å
R-Value Free:
0.23
R-Value Work:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:NAD-dependent protein deacetylase sirtuin-2
Gene (Uniprot):SIRT2
Chain IDs:A
Chain Length:307
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Histone H3.1
Gene (Uniprot):H3C1, H3C2, H3C3, H3C4, H3C6, H3C7, H3C8, H3C10, H3C11, H3C12
Chain IDs:B (auth: C)
Chain Length:7
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural basis of SIRT2 pre-catalysis NAD + binding dynamics and mechanism.
Rsc Chem Biol ? ? ? (2025)
PMID: 40963517 DOI: 10.1039/d5cb00169b

Abstact

Sirtuins are an evolutionarily conserved family of NAD+-dependent deacylases whose catalytic mechanism remains under active investigation. While previous studies have captured sirtuin reaction intermediates using thioacetyl-lysine analogs, here we report six crystal structures of human SIRT2 in complex with native myristoylated peptides and NAD+, revealing the sequence of changes from initial NAD+ binding to the formation of intermediate I. Our structures provide direct structural evidence for: (1) zinc-binding domain shift during NAD+ entry, (2) water-mediated hydrogen-bond formation that disrupts nicotinamide aromaticity preceding cleavage, and (3) the formation of intermediate I. Additionally, we determined the structures of two functionally critical mutants (SIRT2F96A and SIRT2H187A), demonstrating their roles in stabilizing NAD+ in a productive conformation. These findings complete the comprehensive structural framework for the sirtuin deacylation mechanism and highlight key residues governing catalytic efficiency.

Legend

Protein

Chemical

Disease

Primary Citation of related structures